At ICBC Berlin, experts highlight how cGMP, contamination control and post-harvest precision are shaping pharmaceutical-grade cannabis in an increasingly global biomass market.
Inside Red Light Holland’s Plan to Bring Psilocybin Products to the Global Market
Red Light Holland (CSE: TRIP) has established its foundation in the Netherlands, where psilocybin truffles, the underground sclerotia of psilocybin mushrooms, are legally permitted for cultivation and sale. The above-ground mushroom is prohibited, but the truffle is treated differently under Dutch law, despite delivering the same psychoactive effects. “It’s really the same thing, with the…
A Look at the Bloomwell Group’s German Business Model
Tissue culture is emerging as a critical tool in modern cultivation, enabling breeders and cultivators to advance disease-free genetics, consistency, cost efficiency, and scalable production.
Will Target’s move to sell THC drinks be the catalyst the industry needs to push for higher standards? Selling into mass retail is not just about scaling production or packaging appeal. It requires proving that your product meets the same safety and manufacturing standards as food, pharma, and cosmetics.
Experts weigh in on the President’s executive order.
Jason Adelstone, Esq. weighs in on the industry’s legal chaos.
To be able to import cannabis for medical purposes into the EU, it must meet stringent rules and regulations for safety and quality control.
The United Nations Poised To Recognize Cannabis Culture
Beyond its wellness benefits, cannabis carries a rich and diverse cultural legacy that spans the globe. In a technical paper submitted to Mondiacult 2025, the Cannabis Embassy calls for global recognition of cannabis cultures as an integral part of humanity’s cultural diversity, and as essential to building inclusive, rights-based, and peace-oriented cultural policies in the…
Since legalizing medical cannabis in 2022, Thailand has emerged as Southeast Asia’s pioneer in regulated cannabis development with a projected CAGR of 33% over the next five years.
